Genomics is a rapidly evolving field constantly breaking down the boundaries of cost and time efficiency of analysis. Lately, translational and clinical researchers are also looking beyond the genome – at transcriptional, epigenetic and proteomic signatures to reveal new insights into disease aetiology. By taking advantage of new technological developments in this field, biobanks can maximise the value of their samples by identifying and validating multiomic biomarkers and thus creating new opportunities for collaborations with industry, academia, and other organisations.
This webinar will cover recent advances in genomic technology (including sequencing and data analysis), how European biobanks are using genomics and multiomics to increase value of their samples, and how the research community is using genomic/multiomic data from biobanks. for advancing biomedical research.
Join us on 9 November from 14:30 – 16:00 CET to find out more. Register online.
Moderator: Dr. Saba Abdulghani, Head of Biobanking Development, BBMRI-ERIC
Speakers: Dr. Samuel Kroll (Strategic Business Development Manager at Illumina), Dr. Eva Ortega Paíno (Scientific Director of the CNIO Biobank, NN Director of BBMRI.es), Dr. Vita Rovite (Head of the scientific group, senior researcher at LMBC, NN Director of BBMRI.lv)
Access to Detailed Speaker Profiles
Detailed Agenda:
– Recent advances in genomic technology
– Genomics and multiomics – Biobank perspective
– Multiomics data – Research perspective
– Expert panel discussion, Q&A